Lattice Biologics Ltd.
-
Head Office:
512 E. Madison Ave. Suite A1, Belgrade, MT 59714 USA -
Reporting Since:
1996-02-21
Previous Names:
Blackstone Ventures Inc.,Blackstone Resources Inc.
Issuer Status:
Cease Traded as of 2022-02-04
In Default as of 2021-06-02
Year End:
September 30Principal Regulator:
British ColumbiaDefault History
| Period of Default | Default Code | Default From | Default To |
|---|---|---|---|
|
A 2021-09-30
|
1a.,1c.,1e.,3
|
2022-02-01
|
|
|
Q2 2021-03-31
|
3
|
2021-07-09
|
2022-02-04
|
|
Q2 2021-03-31
|
1b.,1c.,1e.,3
|
2021-06-02
|
|
|
Q1 2017-12-31
|
1b.,1c.,1e.,3
|
2018-03-02
|
2018-05-01
|
|
A 2017-09-30
|
1a.,1c.,1e.,3
|
2018-01-30
|
2018-05-01
|
Historical Exempt Distributions
Exempt Distribution filings made after 25-July-2023 can be viewed in SEDAR+
| Exemption | Document Type | Distribution From | Distribution To | $ Amount Raised | Filing Date |
|---|---|---|---|---|---|
|
NI 45-106 2.14
|
2016-12-05
|
2016-12-05
|
889914.0700
|
2017-01-17
|
|
|
NI. 45-106, 2.3(1)
|
2015-12-23
|
2015-12-23
|
117746.7000
|
2016-01-04
|
|
|
NI. 45-106, 2.3(1)
|
2015-12-14
|
2015-12-14
|
200000.4000
|
2015-12-18
|
|
|
NI. 45-106, 2.3(1), NI. 45-106, 2.5(1)
|
2015-10-02
|
2015-10-05
|
1370199.6000
|
2015-10-09
|
|
|
NI. 45-106, 2.14
|
2015-09-29
|
2015-09-29
|
560078.3400
|
2015-10-07
|
|
|
NI. 45-106, 2.3(2)
|
2008-07-09
|
2008-07-09
|
5527599.7500
|
2008-08-26
|
|
|
NI. 45-106, 2.3(2)
|
2007-02-27
|
2007-02-27
|
10350000.0000
|
2007-04-05
|
|
|
NI. 45-106, 2.3(2), NI. 45-106, 2.5(2)
|
2005-10-13
|
2005-10-13
|
4772275.8600
|
2005-11-09
|
|
|
MI. 45-103, s. 5.1(2)
|
2004-08-05
|
2004-08-05
|
1504000.0000
|
2004-08-25
|
|
|
1996 S. 74(2)(9), MI. 45-103, s. 5.1(2)
|
2003-12-19
|
2003-12-19
|
815199.7000
|
2004-02-05
|
|
|
0
|
2000-07-19
|
Exemption Orders
Nothing on File